California State Teachers Retirement System (CalSTRS)
IKT icon

California State Teachers Retirement System (CalSTRS)’s Inhibikase Therapeutics IKT Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio IKT Stock Details IKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.88K Buy
5,883
+2,168
+58% +$3.85K ﹤0.01% 2684
2025
Q4 		$7.62K Sell
3,715
-61
-2% -$97 ﹤0.01% 2876
2025
Q3 		$6.12K Buy
3,776
+3
+0.1% +$5 ﹤0.01% 2959
2025
Q2 		$7.36K Buy
+3,773
New +$7.39K ﹤0.01% 2837

Other funds holding IKT

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

California State Teachers Retirement System (CalSTRS)'s IKT Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its Inhibikase Therapeutics (IKT) stake by 58% in Q1 2026, buying an estimated $3.85K and bringing the position to 5,883 shares worth $9.88K. The position accounts for ﹤0.01% of the portfolio, ranked #2684.

California State Teachers Retirement System (CalSTRS) first reported a position in IKT in Q2 2025 and has held it in 4 quarters since. 104 funds tracked by Wall St. Rank hold IKT as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 5,883 shares of Inhibikase Therapeutics worth $9.88K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) bought 2,168 Inhibikase Therapeutics shares in Q1 2026, an estimated $3.85K.
  • Inhibikase Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2684 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Inhibikase Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • 104 funds tracked by Wall St. Rank held Inhibikase Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.